期刊文献+

简化无血清培养基分离U2-OS人骨肉瘤细胞系肿瘤干细胞 被引量:4

Cancer stem cells from human osteosarcoma cell line U2-OS in a serum-free medium
暂未订购
导出
摘要 背景:已有实验应用成分复杂的无血清培养基从骨肉瘤组织中分离出干细胞样肿瘤细胞。目的:应用简化的无血清培养基在U2-OS人骨肉瘤细胞系中分离培养出骨肉瘤干细胞并对其作肿瘤干细胞的相关检验。设计、时间及地点:干细胞体外培养实验,于2006-02/2007-02在兰州大学第二医院骨科研究所完成。材料:U2-OS人骨肉瘤细胞系购自中科院上海生命科学研究院细胞库。无血清培养基为在DMEM/F12培养基中添加重组表皮生长因子(20μg/L)和重组成纤维生长因子(20μg/L),L-谷氨酰胺(2mmol/L),胰岛素(4U/L),青霉素G(1×l05U/L),链霉素(100mg/L)。方法:取在含血清培养基中贴壁生长的U2-OS细胞,接种于含有表皮生长因子和成纤维生长因子的简化无血清培养基中,形成悬浮生长的骨肉瘤细胞球后观察其增殖、分化能力。用免疫细胞化学染色法检测间充质干细胞标志CD44、CD105蛋白在骨肉瘤细胞球中的表达。反转录-聚合酶链反应法检测U2-OS细胞及其肿瘤干细胞中胚胎多能干细胞管家基因Oct3/4mRNA的表达。主要观察指标:①悬浮细胞球的形成。②肿瘤干细胞增殖活性。③肿瘤干细胞的侵袭能力。④CD44、CD105蛋白在骨肉瘤细胞球细胞中的表达。⑤肿瘤干细胞中Oct3/4mRNA的表达。结果:U2-OS人骨肉瘤细胞系中有极少数的细胞能在简化无血清培养基中增殖形成骨肉瘤细胞球,具有很强的增殖分化能力,其表面具有间充质干细胞的膜分子CD44、CD105,表达胚胎干细胞管家基因Oct3/4mRNA。结论:U2-OS细胞系中存在肿瘤干细胞,简化无血清培养基可用于分离培养骨肉瘤干细胞。 BACKGROUND: Previous studies have used serum-free medium to isolate stem cells-like tumor cells from osteosarcoma tissues. OBJECTIVE: To isolate stem cells from human osteosarcoma cell line U2-OS with serum-free medium and to do relevant tests concerning cancer stem cells. DESIGN, TIME AND SETTING: The stem cell in vitro culture experiment was performed at the Institute of Orthopaedics, Second Hospital, Lanzhou University from February 2006 to February 2007. MATERIALS: U2-OS human osteosarcoma cell line was purchased from Cell Bank, Shanghai Institute of Life Science, Chinese Academy of Sciences. Serum-free medium was the DMEM/F12 medium, supplemented with recombinant epidermal growth factor (20 μg/L), recombinant fibroblast growth factor (20μg/L), L-glutamine (2 mmol/L), insulin (4 U/L), penicillin G (1 xl05 U/L) and streptomycin (100 mg/L). METHODS: Adherent U2-OS cells in serum-supplemented medium were dissociated to single cell suspensions and were seeded in serum-free medium supplemented with epidermal growth factor and fibroblast growth factor. After the sarcospheres formed, proliferation and differentiation potentials were observed. Surface markers of mesenchymal stem cells (CD105 and CD44) were detected by immunocytochemistry. U2-OS cells and marker genes of pludpotent embryonic stem cells (Oct 314 mRNA) were detected by RT-PCR. MAIN OUTCOME MEASURES: Formation of suspended cell spheres; proliferation activity of cancer stem cells; invasion ability of cancer stem cells; CD44 and CD105 protein expression in osteosarcoma cell spheres; Oct3/4 mRNA expression in cancer stem cells. RESULTS: Osteosarcoma sarcospheres could be formed by a small subpopulation cells in U2-OS cell line. These cells were capable of self-renew and proliferation and expressed CD44 and CD 105 and OCt 3/4 m RNA. CONCLUSION: U2-OS cell line contains cancer stem cells that can be isolated with reducing serum-free medium.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2009年第19期3623-3627,共5页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 甘肃省2006年科学事业费项目计划(QS061C3332)~~
  • 相关文献

参考文献4

二级参考文献35

  • 1张毅,李长东,江小霞,李荷莲,唐佩弦,毛宁.Comparison of mesenchymal stem cells from human placenta and bone marrow[J].Chinese Medical Journal,2004(6):882-887. 被引量:13
  • 2康春生,浦佩玉,李捷,于士柱,王虎,江荣才,董伦,王广秀.人脑胶质瘤AKT2表达与细胞增殖和侵袭性的关系[J].中华病理学杂志,2004,33(5):464-465. 被引量:9
  • 3Jean M. Mutant stem cells may seed cancer.Science, 2003, 301: 1308-1310.
  • 4Aubele M, Werner M. Heterogeneity in breast cancer and the problem of relevance of findings. Anal Cell Pathol, 1999, 19: 53-58.
  • 5Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med, 1997, 3: 730-737.
  • 6George AA, Franklin J, Kerkof K, et al. Detection of leukemic cells in the CD34 ( + )CD38( - ) bone marrow progenitor population in children with acute lymphoblastic leukemia. Blood, 2001, 97: 3925-3930.
  • 7Miyamoto T, Weissman IL, Akashi K.AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal transloeation. Proc Natl Acad Sci USA, 2000, 97:7521-7526.
  • 8Fialkow PJ. Stem cell origin of human myeloid blood cell neoplasms. Verh Dtsch Ges Pathol, 1990, 74 : 43-47.
  • 9GroszerM, Erickson R, Scripture - Adams-DD, et al. Negative regulation of neural stern/progenitor cell proliferation by the pten tumor suppressor gene in vivo. Science, 2001,294: 2186-2189.
  • 10Leung C, LingbeekM, Shakhova O, et al.Bmi-1 is essential for cerebellar development and is overexpressed in human meduUoblastomas. Nature, 2004, 428:337-341.

共引文献69

同被引文献50

  • 1欧阳振,王栓科,康学文,王翠芳,汪静,郭洪章.人骨肉瘤细胞株U2-OS中分离并鉴定肿瘤干细胞[J].中国组织工程研究与临床康复,2007,11(24):4706-4709. 被引量:6
  • 2陈正堂.肿瘤分子靶向治疗的临床应用及其思考[J].医学研究生学报,2007,20(8):785-787. 被引量:27
  • 3Makino S. The role of tumor stem-cells in regrowth of the tumor fol- lowing drastic applications [ J ]. Acta Unio Int Contra Cancrum, 1959,15( Suppl 1 ) :196-198.
  • 4Park CH, Bergsagel DE, McCulloch EA. Mouse myeloma tumor stem cells :a primary cell culture assay [ J ]. J Nat1 Cancer Inst, 1971,46(2) :411-422.
  • 5Fujii H, Honoki K,Tsujiucli T, et al. Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines [ J ]. Int J 0ncol,2009,34 (5) : 1381-1386.
  • 6Tirino V, Desiderio V,dtAquino R, et al. Detection and character- izafion of CD133+ cancer stem ceils in human solid tumours [ J]. PLoS ONE,2008,3(10) :e3469.
  • 7Murase M, Kano M, Tsukahara T, et al. Side population cells have the characteristics of cancer stem-like ceUs/cancer-initiating cells in bone sarcomas[ J]. Br J Cancer,2009,101 (8) :1425-1432.
  • 8Yang M,Zhang R, Yah M, et al. Detection and characterization of side population in Ewing sarcoma SK-ES-1 cells in vitro [ J ]. Bio- chem Biophys Res Commun ,2010,391 ( 1 ) : 1062-1106.
  • 9Naka N,Takenaka S, Araki N,et al. Synovial sarcoma is a stem cell malignancy[J]. Stem Cells,2010,28(7) :1119-1131.
  • 10Tabu K, Kimura T, Sasai K, et al. Analysis of an alternative human CDI33 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks[ J]. Mol Cancer,2010,9:39.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部